Drug Discovery
Tag
May 23, 2024
![Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics](https://oicr.on.ca/wp-content/uploads/2024/05/Providence-Therapeutics-Press-Releases-White-Logo-f5c6f5eda48b9918e8c37a4d8a067ed3-e1716399191585.jpg)
Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics
Jun 28, 2023
![The Next Generation: Aisha Naamani](https://oicr.on.ca/wp-content/uploads/2023/06/next-gen-websiteimage-aisha.jpg)
The Next Generation: Aisha Naamani
Mar 14, 2023
![The Next Generation: Hector Gonzalez Alvarez](https://oicr.on.ca/wp-content/uploads/2023/03/hector-next-gen.jpg)
The Next Generation: Hector Gonzalez Alvarez
Jan 12, 2023
![Drug Discovery scientist wants to speed up development of new cancer therapeutics](https://oicr.on.ca/wp-content/uploads/2023/01/Masoud-Vedadi-1-scaled.jpg)
Drug Discovery scientist wants to speed up development of new cancer therapeutics
Sep 27, 2022
![The Next Generation: Mahmoud Noureldin](https://oicr.on.ca/wp-content/uploads/2022/09/Mahmoud-lab.jpg)
The Next Generation: Mahmoud Noureldin
Aug 29, 2022
![Previously overlooked proteins are a potential source for a new class of cancer killing drugs](https://oicr.on.ca/wp-content/uploads/2022/08/Drug_Discovery_lab.jpg)
Previously overlooked proteins are a potential source for a new class of cancer killing drugs
Nov 25, 2020
![Cancer research through COVID: A drug discovery student's perspective](https://oicr.on.ca/wp-content/uploads/2020/10/vivian.jpg)
Cancer research through COVID: A drug discovery student's perspective
Jul 21, 2020
![OICR Drug Discovery awarded for COVID-19 research](https://oicr.on.ca/wp-content/uploads/2020/07/gena-covid-19.jpg)
OICR Drug Discovery awarded for COVID-19 research
Jun 17, 2020
![Inside OICR’s Drug Discovery Lab: A graduate student’s unique collaborative experience](https://oicr.on.ca/wp-content/uploads/2020/06/Deeba-Ensan.jpg)
Inside OICR’s Drug Discovery Lab: A graduate student’s unique collaborative experience
Jun 16, 2020
![OICR joins European consortium to ‘enable and unlock biology in the open’](https://oicr.on.ca/wp-content/uploads/2020/06/Richard_Marcellus.jpg)
OICR joins European consortium to ‘enable and unlock biology in the open’
Jun 11, 2020
![Community-driven initiative finds new potential avenue of ovarian cancer treatment](https://oicr.on.ca/wp-content/uploads/2020/06/Trevor-Shepherd.jpg)
Community-driven initiative finds new potential avenue of ovarian cancer treatment
May 20, 2020
![Study points to common protein duo as a new therapeutic target for several cancer types](https://oicr.on.ca/wp-content/uploads/2020/05/RUVBL1.jpg)
Study points to common protein duo as a new therapeutic target for several cancer types
Feb 27, 2020
![Innovative drug screening method finds new promising molecules to treat aggressive lung cancers](https://oicr.on.ca/wp-content/uploads/2020/02/Joint-pic.jpg)
Innovative drug screening method finds new promising molecules to treat aggressive lung cancers
Nov 01, 2019
![Dr. Rima Al-awar promoted to Head of Therapeutic Innovation and Drug Discovery at OICR](https://oicr.on.ca/wp-content/uploads/2019/11/rima-banner-e1624976334424.jpg)
Dr. Rima Al-awar promoted to Head of Therapeutic Innovation and Drug Discovery at OICR
Jul 24, 2019
![OICR funding for Ontario drug discovery projects will accelerate development of new cancer therapies](https://oicr.on.ca/wp-content/uploads/2019/07/CTIP.jpg)
OICR funding for Ontario drug discovery projects will accelerate development of new cancer therapies
May 21, 2019
![Activating the immune system to fight cancer](https://oicr.on.ca/wp-content/uploads/2019/05/bri-panel.jpg)
Activating the immune system to fight cancer
Mar 08, 2019
![Moving in vivo: A case of navigating through translational research roadblocks](https://oicr.on.ca/wp-content/uploads/2019/03/translating1.jpg)
Moving in vivo: A case of navigating through translational research roadblocks
Feb 21, 2019
![OICR supports cancer drug discovery in Ontario with new funding for four promising early-stage projects](https://oicr.on.ca/wp-content/uploads/2021/11/oicr-logo-hyphen-inspired.jpg)
OICR supports cancer drug discovery in Ontario with new funding for four promising early-stage projects
Jan 29, 2019
![First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment](https://oicr.on.ca/wp-content/uploads/2019/01/Rodan-OICR-012919-283-edit.jpg)
First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment
Sep 13, 2018
![FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants](https://oicr.on.ca/wp-content/uploads/2016/11/facit.png)
FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants
Sep 04, 2018
![Meet our students - 2018](https://oicr.on.ca/wp-content/uploads/2018/09/students.jpg)
Meet our students - 2018
Aug 22, 2018
![Meet the researchers: Ratheesh Subramaniam](https://oicr.on.ca/wp-content/uploads/2018/08/ratheesh.jpg)
Meet the researchers: Ratheesh Subramaniam
Jul 31, 2018
![Can an open drug discovery model find a solution for rare brain cancers in children?](https://oicr.on.ca/wp-content/uploads/2018/07/aled.jpg)
Can an open drug discovery model find a solution for rare brain cancers in children?
Dec 04, 2017
![OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic](https://oicr.on.ca/wp-content/uploads/2017/11/ctip-thumb.jpg)
OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic
Mar 22, 2017
![FACIT Announces Investment in Propellon Therapeutics](https://oicr.on.ca/wp-content/uploads/2017/03/Propellon-knockout.png)
FACIT Announces Investment in Propellon Therapeutics
Feb 10, 2017
![How chemical probes can boost cancer research](https://oicr.on.ca/wp-content/uploads/2016/06/david-lab.jpg)
How chemical probes can boost cancer research
Dec 06, 2016
![Congratulations to Ahmed Aman on another successful Movember fundraiser](https://oicr.on.ca/wp-content/uploads/2016/12/Ahmed_Aman.jpg)
Congratulations to Ahmed Aman on another successful Movember fundraiser
Sep 19, 2016
![Open resource: How we’re making our research resources more accessible to the community](https://oicr.on.ca/wp-content/uploads/2016/09/crr-blog.jpg)
Open resource: How we’re making our research resources more accessible to the community
Aug 18, 2016
![Registration now open for the Mark Ernsting Drug Discovery Memorial Lecture](https://oicr.on.ca/wp-content/uploads/2016/08/mark-lecture.jpg)
Registration now open for the Mark Ernsting Drug Discovery Memorial Lecture
Jul 26, 2016
![OICR is making its technology infrastructure, expertise and resources more available to the Ontario cancer community](https://oicr.on.ca/wp-content/uploads/2016/07/tech-access.jpg)
OICR is making its technology infrastructure, expertise and resources more available to the Ontario cancer community
Jul 18, 2016
![Save the date: Mark Ernsting Drug Discovery Memorial Lecture on September 22, 2016](https://oicr.on.ca/wp-content/uploads/2016/07/mark-site-e1634242049339.jpg)
Save the date: Mark Ernsting Drug Discovery Memorial Lecture on September 22, 2016
Jun 21, 2016
![Ask an expert: How are new cancer drugs created?](https://oicr.on.ca/wp-content/uploads/2016/06/david-lab.jpg)
Ask an expert: How are new cancer drugs created?
May 01, 2016
![OICR invests in early-stage Ontario oncology drug development](https://oicr.on.ca/wp-content/uploads/2021/10/oicr-abstact-bkg-4.jpg)
OICR invests in early-stage Ontario oncology drug development
Jan 07, 2016
![Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario](https://oicr.on.ca/wp-content/uploads/2021/10/oicr-abstact-bkg-4.jpg)
Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario
Dec 29, 2015
![OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers](https://oicr.on.ca/wp-content/uploads/2016/04/FACIT-square.jpg)
OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers
Dec 08, 2015
![FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia](https://oicr.on.ca/wp-content/uploads/2017/02/OICR_FACIT.jpg)
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Dec 08, 2015
![FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia](https://oicr.on.ca/wp-content/uploads/2017/02/OICR_FACIT.jpg)
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Oct 14, 2015
![OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers](https://oicr.on.ca/wp-content/uploads/2021/10/oicr-abstact-bkg.jpg)
OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers
Sep 03, 2015
![The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research](https://oicr.on.ca/wp-content/uploads/2021/10/cliche.jpg)
The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.